𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Veno-active drugs for chronic venous disease: A randomized, double-blind, placebo-controlled parallel-design trial

✍ Scribed by Belczak, S. Q.; Sincos, I. R.; Campos, W.; Beserra, J.; Nering, G.; Aun, R.

Book ID
121462653
Publisher
Royal Society of Medicine Press
Year
2013
Tongue
English
Weight
241 KB
Volume
29
Category
Article
ISSN
0268-3555

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease
✍ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 486 KB πŸ‘ 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease
✍ Kitty K. Wong; Jane E. Alty; Amanda G. Goy; Sanjay Raghav; David C. Reutens; Pet πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 565 KB

## Abstract ## Background: This randomized double blind, placebo‐controlled crossover study investigated the antidyskinetic effects of levetiracetam in Parkinson's disease. ## Methods: Sixteen participants with levodopa‐induced dyskinesia were enrolled. Hourly videotaped dyskinesia assessments s